Nicotine Vapes Beat Patches and Gum for Smoking Cessation, 30,000-Person Cochrane Review Finds

Nicotine e-cigarettes help people quit traditional tobacco more effectively than standard nicotine replacement therapy, such as patches, sprays, and gums. That is the conclusion of an updated systematic review by the respected research network Cochrane, which combined data from 80 randomized clinical trials involving 29,861 smokers.

By the Numbers: A 61% Advantage Over Patches

The primary measure of success in the review was total abstinence from combustible cigarettes for at least six months.

According to the summary of results in PubMed, for every 100 people attempting to quit smoking:

• 8 to 10 people successfully quit entirely when switching to nicotine e-cigarettes;
• about 6 people manage to overcome their addiction using traditional nicotine patches or gum (NRT);
• about 6 people quit when using nicotine-free vapes;
• about 5 people succeed with only psychological support or no specialized assistance at all.

In a comparative analysis, the likelihood of successfully quitting smoking with nicotine vapes was 61% higher than with standard nicotine replacement therapy (roughly 4 additional quitters per 100 people). Cochrane experts assigned a high level of certainty to this finding.

The Psychology of Ritual: Why Vaping Delivers Nicotine Better

As noted in a press release from Cochrane, the advantage of vapes goes beyond the pharmacological action of nicotine.

Patches and pills relieve physical cravings but do not address the behavioral habit. E-cigarettes preserve hand-to-mouth motor habits, the characteristic throat sensation (throat hit), rapid nicotine absorption in the bloodstream, and social rituals, reducing psychological stress when giving up combustible tobacco.

The Danger of Dual Use and Safety Considerations

The study authors emphasize that these findings do not imply vaping is completely harmless.

Key caveats highlighted by the researchers:

• Harm assessment: Over the timeframes studied, the frequency of serious adverse events from vapes did not exceed that of patches; however, evaluating multi-year systemic risks requires further monitoring;
• Certified devices only: The analysis focused on controlled liquids and devices, not counterfeit or unknown single-use disposable vapes;
• Risk of dual use: Guidance from the US Centers for Disease Control and Prevention (CDC) notes that simultaneously smoking regular cigarettes and vaping (dual use) does not reduce health risks — therapeutic benefits are achieved only with a complete transition away from tobacco combustion.

International Regulatory Approaches

Regulatory stances on electronic devices vary dramatically by country:

• United Kingdom: Health body NICE officially incorporates nicotine e-cigarettes into harm reduction guidance for adult smokers;
• United States: The Food and Drug Administration (FDA) has not approved any vape as an official smoking cessation medication;
• WHO: The World Health Organization urges prioritizing proven medications (such as varenicline and cytisine) alongside psychological support programs.

Medical professionals conclude that non-smokers should strictly avoid vaping; however, for long-term smokers, fully switching to regulated electronic nicotine delivery systems offers a scientifically backed tool to quit the most toxic form of tobacco consumption.